Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Cancer|May 27, 2003
Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology GroupRobert Dreicer, Judith Manola, Daniel J Schneider, et al.
BJU International|October 13, 2006
Sperm banking: use and outcomes in patients treated for testicular cancerChristopher R Girasole, Michael S Cookson, Joseph A Smith, et al.
Cancer|April 10, 2004
Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urotheliumRobert Dreicer, Judith Manola, Bruce J Roth, et al.
American Journal of Clinical Oncology|October 8, 2008
A phase I trial of irinotecan alternating with epirubicin in patients with advanced malignanciesLaura W Goff, Mace L Rothenberg, A Craig Lockhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urotheliumChristopher J Sweeney, Bruce J Roth, Fairooz F Kabbinavar, et al.
Investigational New Drugs|March 19, 2021
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I studyKatrina S Pedersen, Patrick M Grierson, Joel Picus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
A phase I dose-escalation and pharmacokinetic study of brostallicin (PNU-166196A), a novel DNA minor groove binder, in adult patients with advanced solid tumorsA Craig Lockhart, Martin Howard, Kenneth R Hande, et al.
Proteomics. Clinical Applications|September 28, 2011
Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexesEarle F Burgess, Amy-Joan L Ham, David L Tabb, et al.
The Journal of Urology|May 14, 2013
Castration-resistant prostate cancer: AUA GuidelineMichael S Cookson, Bruce J Roth, Philipp Dahm, et al.
Clinical Genitourinary Cancer|November 28, 2017
Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) TrialYu-Ning Wong, Judith Manola, Gary R Hudes, et al.
Pageof 4